News related to Plenaxis (Abarelix) and/or conditions it is approved for
Time Between Treatment And PSA Recurrence Predicts Death From Prostate Cancer
Source: Health News from Medical News Today [2009.11.05]
Men whose prostate specific antigen (PSA) rise within 18 months of radiotherapy are more likely to develop spread and die of their disease, according to an international study led by Fox Chase Cancer Center radiation oncologist Mark K. Buyyounouski, M.D., M.S. and presented at the annual meeting of the American Society for Radiation Oncology (ASTRO).
Men Urged To Seek Advice Due To Faulty Prostate Cancer Home Test Kits
Source: Cancer / Oncology News From Medical News Today [2009.11.05]
Men who have used 'Simplicity Health' or 'Fortel' home testing kits for prostate cancer screening during the past 12 months are being urged to contact their GP for advice. This follows recent notification to the Medicines and Healthcare products Regulatory Agency (MHRA) that the two kits from batch number 1012 are faulty and could give a false negative result. The 1000 defective devices shipped to the UK were sold through pharmacies and via the internet.
Study Of Race, Income And Prostate Cancer Outcome
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.05]
A patient's socioeconomic status (income, marital status and race) has absolutely no impact on his outcome following curative radiation therapy for the treatment of prostate cancer, according to a new study from Henry Ford Hospital in Detroit. "This study offers an extremely important message for all patients with prostate cancer who receive radiation therapy," says Benjamin Movsas, M.D.
Blood Vessels Might Predict Prostate Cancer Behavior
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.05]
A diagnosis of prostate cancer raises the question for patients and their physicians as to how the tumor will behave. Will it grow quickly and aggressively and require continuous treatment, or slowly, allowing therapy and its risks to be safely delayed? The answer may lie in the size and shape of the blood vessels that are visible within the cancer, according to research led by investigators at The Ohio State University Comprehensive Cancer Center-Arthur G.
Red, processed meats linked to prostate cancer (Reuters)
Source: Y! Health Cancer & Chemotherapy News [2009.11.05]
Reuters - Men who eat a lot of red meat and processed meats may have a higher risk of developing prostate cancer than those who limit such foods, a large study of U.S. men suggests.
Proton Boost May Thwart Prostate Cancer's Return
Source: MedicineNet Cancer Specialty [2009.11.05]
Title: Proton Boost May Thwart Prostate Cancer's Return
Category: Health News
Created: 11/5/2009 10:12:00 AM
Last Editorial Review: 11/5/2009 10:12:51 AM
Risk For High-Grade Prostate Cancer May Be Reduced By Low Cholesterol
Source: Cholesterol News From Medical News Today [2009.11.04]
Men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer - an aggressive form of the disease with a poorer prognosis, according to results of a Johns Hopkins collaborative study. In a prospective study of more than 5,000 U.S. men, epidemiologists say they now have evidence that having lower levels of heart-clogging fat may cut a man's risk of this form of cancer by nearly 60 percent.
Shorter Radiation Course As Effective As Standard Therapy For Prostate Cancer Recurrence
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.04]
A shorter, five-week course of radiation treatment that delivers higher doses of radiation in fewer sessions, known as hypofractionation, appears to be just as effective and as safe in reducing the risk of prostate cancer from returning as standard radiation therapy, yet is delivered in two-and-a-half weeks less time, according to interim results of a randomized study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
In Prostate Cancer Patients Proton Therapy Is Well-Tolerated
Source: GastroIntestinal / Gastroenterology News From Medical News Today [2009.11.03]
Proton beam therapy can be safely delivered to men with prostate cancer and has minimal urinary and rectal side effects, according to a study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.
Prostate Cancer Recurrences Reduced By Adding Proton Therapy "Boost" To X-Ray Radiation Therapy
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.03]
Men who receive a "boost" of proton therapy after receiving a standard course of X-ray radiation therapy have fewer recurrences of their prostate cancer compared to men who did not receive the extra dose of proton radiation, according to a first-of-its-kind study presented November 2, 2009, at the American Society for Radiation Oncology's 51st Annual Meeting in Chicago.
Short-Term Hormone Therapy And Intermediate Dose Radiation Increases Survivial For Early Stage Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.03]
Short-term hormone therapy given prior to and during intermediate dose radiation treatment for men with early stage prostate cancer increases their chance of living longer, compared to those who receive the same radiation alone, according to a Radiation Therapy Oncology Group (RTOG) study, the largest randomized trial of its kind, presented November 2, 2009, at the American Society for Radiation Oncology (ASTRO) annual meeting.
Short-term Hormone Therapy Added To Radiation Increases Survival For Medium-risk, But Not Low-risk, Prostate Cancer Patients
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.03]
Short-term hormone therapy given prior to and during radiation treatment to medium-risk prostate cancer patients increases their chance of living longer, compared to those who receive radiation alone, however there is no significant benefit for low-risk patients, according to the largest randomized study of its kind presented at the plenary session November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
ASTRO: Hormones Plus Radiation Ups Survival in Prostate Cancer (CME/CE, with video)
Source: MedPage Today Hematology/Oncology [2009.11.03]
CHICAGO (MedPage Today) -- Short-term androgen deprivation therapy significantly improved survival when added to radiation therapy for intermediate-risk prostate cancer, data from a large, multicenter clinical trial showed.
Low cholesterol may prevent some prostate cancers (AP)
Source: Y! Health Cholesterol News [2009.11.03]
AP - Men may protect more than their hearts if they keep cholesterol in line: Their chances of getting aggressive prostate cancer may be lower, new research suggests.
Hormone Therapy Can Help Some With Prostate Cancer
Source: MedicineNet Cancer Specialty [2009.11.03]
Title: Hormone Therapy Can Help Some With Prostate Cancer
Category: Health News
Created: 11/2/2009 2:10:00 PM
Last Editorial Review: 11/3/2009
Studies Show Early Promise Of MannKind's Cancer Immunotherapy Program In Melanoma, Prostate Cancer And Other Solid Malignancies
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.02]
Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies. The data are being presented at the International Society for Biological Therapy of Cancer 2009 Annual Meeting.
Erlotinib Has Moderate Single-agent Activity In Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results Of A Phase II Trial
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.02]
UroToday.com - This was an open label single institution study that looked at the activity and toxicity of single agent erlotinib in patients with CRPC who have not received chemotherapy yet. The mechanisms by which prostate cancer becomes castration resistant are variable and multiple. One hypothesis is that the overexpression of the epidermal growth factor receptor (EGFR) allows for downstream cell signaling causing cancer cell growth and proliferation.
Hormone Therapy Can Help Some With Prostate Cancer (HealthDay)
Source: Y! Health Breast Cancer News [2009.11.02]
HealthDay - MONDAY, Nov. 2 (HealthDay News) -- A brief course of hormone-blocking
therapy can provide small benefits to a specific group of men who get
radiation therapy for prostate cancer, a long-running study shows.
Safety And Immunological Efficacy Of A DNA Vaccine Encoding Prostatic Acid Phosphatase In Patients With Stage D0 Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.01]
UroToday.com - In the online edition of the Journal of Clinical Oncology, Dr. Douglas McNeel and associates report a phase I/IIa trial of a DNA vaccine encoding prostatic acid phosphatase (PAP) in patients with stage D0 prostate cancer (CaP). PAP is a prostate tumor antigen that can elicit an immunologic antigen-specific CD8+ T cell response. The vaccine, pTVG-HP, is a plasmid DNA encoding the full length human PAP cDNA downstream of a eukaryotic promoter.
Prostate Cancer-specific Mortality After Radical Prostatectomy For Patients Treated In The Prostate-specific Antigen Era
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.01]
UroToday.com - In the online edition of the Journal of Clinical Oncology, a multi-institutional study reports on prostate cancer (CaP)-specific mortality after radical prostatectomy (RP) treated since the introduction of PSA. The study sought to establish a predictive nomogram and modeled the nomogram on 6,398 patients treated with RP at Baylor and MSKCC between 1987 and 2005.
Racial Differences In Trust And Regular Source Of Patient Care And The Implications For Prostate Cancer Screening Use
Source: Prostate / Prostate Cancer News From Medical News Today [2009.10.31]
UroToday.com - An article in the online edition of Cancer assesses differences in prostate cancer (CaP) treatment, trust and regular patient care based upon patient race. The North Carolina-Louisiana prostate Cancer Project (PCaP) is a population-based study of men identified shortly after CaP diagnosis. Enrollment began in 2004, however there was a temporary study enrollment lapse in Louisiana due to Hurricane Katrina.
Male Hormone May Trigger Gene Fusion That Leads To Prostate Cancer, Study
Source: Prostate / Prostate Cancer News From Medical News Today [2009.10.30]
Researchers in the US have discovered that the male hormone androgen may trigger the gene fusion that leads to the development of prostate cancer: they found that pieces of chromosome that normally sit far apart, relocate near each other after exposure to androgen, and this sets the scene for the genes to fuse.
New Bcl-2 Inhibitor Shows Promise In Cell Death In Prostate Cancer
Source: Prostate / Prostate Cancer News From Medical News Today [2009.10.27]
In trying to better predict a patient's response to chemotherapy for cancer treatment, a team of investigators at The Cancer Institute of New Jersey (CINJ) and Rutgers, The State University of New Jersey, has identified a way to better manipulate a gene product to cause cancer cells to die. And in order to further examine this mechanism, researchers also created a new vehicle for pre-clinical testing of cancer treatments that acts as a bridge between experimental models and human subjects.
Replication Of Prostate Cancer Risk Loci In A Japanese Case-Control Association Study
Source: Prostate / Prostate Cancer News From Medical News Today [2009.10.27]
Genome-wide association studies can identify genetic allele variants of low penetrance that are strongly associated with cancer. This has been reported for prostate cancer (CaP) in a cohort of men with European ancestry. In the online edition of the Journal of the National Cancer Institute, Dr. Yamada and associates evaluate the association of 23 risk single-nucleotide polymorphisms (SNPs) and clinical characteristics with CaP in a cohort of Japanese men.
New Test Checks for Prostate Cancer Return
Source: MedicineNet Cancer Prevention Specialty [2009.10.20]
Title: New Test Checks for Prostate Cancer Return
Category: Health News
Created: 10/20/2009 11:07:00 AM
Last Editorial Review: 10/20/2009 11:07:22 AM
PSA 'Nanotest' May Spot Prostate Cancer's Return After
Surgery (HealthDay)
Source: Y! Health Prostate Cancer News [2009.10.19]
HealthDay - MONDAY, Oct. 19 (HealthDay News) -- A new test that could
revolutionize the treatment of men following prostate cancer surgery has
worked well in a small, early trial, researchers report.
Exercise May Prevent Prostate Cancer: Study
Source: MedicineNet Prostate Cancer Specialty [2009.09.28]
Title: Exercise May Prevent Prostate Cancer: Study
Category: Health News
Created: 9/25/2009 4:10:00 PM
Last Editorial Review: 9/28/2009
Hormone Therapy for Prostate Cancer Raises Heart Risks
Source: MedicineNet Congestive Heart Failure Specialty [2009.09.23]
Title: Hormone Therapy for Prostate Cancer Raises Heart Risks
Category: Health News
Created: 9/22/2009 2:10:00 PM
Last Editorial Review: 9/23/2009
STD Linked to Prostate Cancer
Source: MedicineNet Prostate Specific Antigen Specialty [2009.09.14]
Title: STD Linked to Prostate Cancer
Category: Health News
Created: 9/14/2009 11:22:00 AM
Last Editorial Review: 9/14/2009 11:22:01 AM
Prostate Cancer Over-Diagnosed: Study
Source: MedicineNet Urinary Incontinence Specialty [2009.09.01]
Title: Prostate Cancer Over-Diagnosed: Study
Category: Health News
Created: 8/31/2009 4:10:00 PM
Last Editorial Review: 9/1/2009
Hormone Therapy for Early Prostate Cancer Not Always Best
Source: MedicineNet Hormone Therapy Specialty [2009.08.26]
Title: Hormone Therapy for Early Prostate Cancer Not Always Best
Category: Health News
Created: 8/25/2009 4:10:00 PM
Last Editorial Review: 8/26/2009
Oral Drug Ups Survival in Advanced Prostate Cancer Cases
Source: MedicineNet Hormone Therapy Specialty [2009.08.11]
Title: Oral Drug Ups Survival in Advanced Prostate Cancer Cases
Category: Health News
Created: 8/11/2009 8:00:00 AM
Last Editorial Review: 8/11/2009
Erectile Aid Use By Men Treated For Localized Prostate Cancer
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2009.08.10]
UroToday.com - A UCLA single-institution study in the online edition of the Journal of Urology reports on the use of erectile aid (EA) following treatment for localized prostate cancer (CaP). Participants with a diagnosis of CaP were prospectively recruited between 1999 and 2003. Clinical and pathological data was abstracted and HRQOL (Health Related Quality of Life) outcomes were prospectively abstracted at baseline and 1, 2, 4, 8, 12, 18, 24, 30, 36, 42 and 48 months.
Oncological Results, Functional Outcomes, Quality-of-Life - Radical Prostatectomy Or External Beam Radiation Therapy For Localized Prostate Cancer
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2009.08.03]
UroToday.com - Most recently, health-related quality-of-life (HRQOL) after definitive local therapy for prostate cancer has been argued in the patient group with an oncological risk category.
Men Who Have Prostate Cancer Surgery Do Well
Source: MedicineNet Urinary Incontinence Specialty [2009.07.28]
Title: Men Who Have Prostate Cancer Surgery Do Well
Category: Health News
Created: 7/28/2009 7:00:00 AM
Last Editorial Review: 7/28/2009
Green Tea Component May Slow Prostate Cancer
Source: MedicineNet Prostate Specific Antigen Specialty [2009.06.22]
Title: Green Tea Component May Slow Prostate Cancer
Category: Health News
Created: 6/20/2009 7:00:00 AM
Last Editorial Review: 6/22/2009
Study Details Quality Of Life For Prostate Cancer Patients Four Years Out From Treatment
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2009.06.10]
A long-term study by researchers at UCLA's Jonsson Comprehensive Cancer Center found that the three most common treatments for localized prostate cancer had significant impacts on patients' quality of life, a finding that could help guide doctors and patients in making treatment decisions.
Gene Test Helps Detect Prostate Cancer
Source: MedicineNet Prostate Specific Antigen Specialty [2009.06.01]
Title: Gene Test Helps Detect Prostate Cancer
Category: Health News
Created: 6/1/2009 7:00:00 AM
Last Editorial Review: 6/1/2009
Prostate Cancer Vaccine Meets Goal
Source: MedicineNet Tremor Specialty [2009.04.15]
Title: Prostate Cancer Vaccine Meets Goal
Category: Health News
Created: 4/15/2009
Last Editorial Review: 4/15/2009
Folic Acid May Raise Prostate Cancer Risk
Source: MedicineNet Colon Polyps Specialty [2009.03.11]
Title: Folic Acid May Raise Prostate Cancer Risk
Category: Health News
Created: 3/11/2009
Last Editorial Review: 3/11/2009
Drug May Help Prevent Prostate Cancer
Source: MedicineNet Benign Prostatic Hyperplasia Specialty [2009.02.25]
Title: Drug May Help Prevent Prostate Cancer
Category: Health News
Created: 2/25/2009
Last Editorial Review: 2/25/2009
Degarelix Approved for Advanced Prostate Cancer
Source: MedicineNet leuprolide Specialty [2008.12.30]
Title: Degarelix Approved for Advanced Prostate Cancer
Category: Health News
Created: 12/30/2008 2:00:00 AM
Last Editorial Review: 12/30/2008
Treatment Options Are Many for Prostate Cancer
Source: MedicineNet Overactive Bladder Specialty [2008.12.08]
Title: Treatment Options Are Many for Prostate Cancer
Category: Health News
Created: 12/6/2008 2:00:00 AM
Last Editorial Review: 12/8/2008
Prostate Cancer Therapy May Not Help
Source: MedicineNet leuprolide Specialty [2008.07.09]
Title: Prostate Cancer Therapy May Not Help
Category: Health News
Created: 7/9/2008
Last Editorial Review: 7/9/2008
Prostate Cancer
Source: MedicineNet Hydronephrosis Specialty [2007.06.04]
Title: Prostate Cancer
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 6/4/2007
Lifestyle, diet may stop or reverse prostate cancer progression
Source: The Doctors Lounge - Urology
The research is the first randomized, controlled trial to show that lifestyle changes may affect cancer progression.
ASTRO: Statins May Boost Effects of Prostate Radiation (CME/CE)
Source: MedPageToday.com - medical news plus CME for physicians [2009.11.05]
CHICAGO (MedPage Today) -- Prostate cancer patients had a reduced risk of biochemical failure if they were taking a statin during radiation therapy, data from a retrospective cohort study showed.
Answers And Some New Questions Concerning Cholesterol And Cancer
Source: Cancer / Oncology News From Medical News Today [2009.11.04]
A pair of studies in Cancer Epidemiology, Biomarkers & Prevention, lay to rest the decades-long concern that lower total cholesterol may lead to cancer, and in fact lower cholesterol may reduce the risk of high-grade prostate cancer. Demetrius Albanes, M.D., a senior investigator at the National Cancer Institute, said early studies suggested that low cholesterol could increase the risk of certain types of cancer.
Studies Negate Concerns That Low Cholesterol Leads To Some Cancers
Source: Cancer / Oncology News From Medical News Today [2009.11.04]
Two new studies from the US published this week negate concerns that have been around since early studies done decades ago suggested that low cholesterol leads to some types of cancer: one in fact affirms that undiagnosed cancer is the likely cause of lower total cholesterol while the other found evidence linking low cholesterol and decreased risk of high-grade prostate cancer among older men.
PSA Reading Could Predict Post-Radiation Survival (HealthDay)
Source: Y! Health Cancer & Chemotherapy News [2009.11.04]
HealthDay - WEDNESDAY, Nov. 4 (HealthDay News) -- Prostate cancer patients
whose prostate-specific antigen (PSA) levels rise within 18 months after
radiotherapy have an increased risk of death, say U.S. researchers.
Undetectable PSA After Radiation Is Possible And Predicts Good Patient Outcomes
Source: Prostate / Prostate Cancer News From Medical News Today [2009.11.03]
Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA after therapy have less chance of biochemical failure than other patients and a good chance of being cured. The data was presented at the annual meeting of the American Society for Radiation Oncology.
Low cholesterol may be sign of undiagnosed cancer (Reuters)
Source: Y! Health Cholesterol News [2009.11.03]
Reuters - Low total cholesterol may be a sign of cancer rather than a cause, as some researchers have suggested, and men who have low cholesterol actually have a lower risk of developing high-risk prostate cancer, two teams reported on Tuesday.
Study Uncovers Key To How 'Triggering Event' In Cancer Occurs
Source: Prostate / Prostate Cancer News From Medical News Today [2009.10.30]
Researchers at the University of Michigan Comprehensive Cancer Center have discovered what leads to two genes fusing together, a phenomenon that has been shown to cause prostate cancer to develop. The study found that pieces of chromosome relocate near each other after exposure to the hormone androgen. This sets the scene for the gene fusion to occur. The finding is reported online Oct. 29 in Science Express.
November Is Lung Cancer Month: Know The Latest Information About This Deadliest Of Cancers
Source: Lung Cancer News From Medical News Today [2009.10.29]
Lung cancer is the world's most common cancer, and an estimated 219,440 Americans are expected to be diagnosed this year.(1) It is also estimated that lung cancer will cause 159,000 deaths in the United States this year - more than the total number of deaths resulting from breast, colon and prostate cancers combined.
New Body Of Research Suggests Statin Use Benefits Multiple Areas Of Urologic Health
Source: Erectile Dysfunction / Premature Ejaculation News From Medical News Today [2009.04.28]
Several new studies presented at the American Urological Association's (AUA) 104th Annual Scientific Meeting suggest that the use of statins--commonly prescribed to lower cholesterol--may benefit men with prostate cancer, erectile dysfunction or lower urinary tract symptoms (LUTS). Several key research studies highlighting these benefits will be presented during a special panel for the media on Monday, April 27 from 9 to 10:30 a.m.
|
